;PMID: 1763524
;source_file_1008.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..36] = [t:0..36]
;1)sentence:[e:42..126] = [t:42..126]
;2)section:[e:130..175] = [t:130..175]
;3)section:[e:179..268] = [t:179..268]
;4)sentence:[e:272..409] = [t:272..409]
;5)sentence:[e:410..530] = [t:410..530]
;6)sentence:[e:531..702] = [t:531..702]
;7)sentence:[e:703..906] = [t:703..906]
;8)sentence:[e:907..1075] = [t:907..1075]
;9)sentence:[e:1076..1162] = [t:1076..1162]
;10)sentence:[e:1163..1362] = [t:1163..1362]
;11)section:[e:1366..1410] = [t:1366..1409]
;Sentence Matching Errors
;ERROR_Section end mismatch[e:1366..1410][t:1366..1409]
;Token/POS Errors
;ERROR_Token in entity file but not tree[1409..1410] ]
;ERROR_POS mismatch [1137..1140] t:token e:CD 6.7

;section 0 Span:0..36
;Xenobiotica. 1991 Nov;21(11):1501-9.
(SEC
  (FRAG (RB:[0..11] Xenobiotica) (IN:[11..12] .) (CD:[13..17] 1991)
        (CC:[18..25] Nov;21-LRB-) (CD:[25..27] 11) (-RRB-:[27..28] -RRB-)
        (CD:[28..33] :1501) (::[33..34] -) (CD:[34..36] 9.)))

;sentence 1 Span:42..126
;Thebaine O-demethylation to oripavine: genetic differences between two rat 
;strains.
;[42..50]:substance:"Thebaine"
;[70..79]:substance:"oripavine"
(SENT
  (NP-HLN
    (NP
      (NP (NN:[42..50] Thebaine) (NN:[51..66] O-demethylation))
      (PP (TO:[67..69] to)
        (NP (NN:[70..79] oripavine))))
    (::[79..80] :)
    (NP
      (NP (JJ:[81..88] genetic) (NNS:[89..100] differences))
      (PP (IN:[101..108] between)
        (NP (CD:[109..112] two) (NN:[113..116] rat) (NNS:[118..125] strains))))
    (.:[125..126] .)))

;section 2 Span:130..175
;Mikus G, Somogyi AA, Bochner F, Eichelbaum M.
(SEC
  (FRAG (NNP:[130..135] Mikus) (NNP:[136..137] G) (,:[137..138] ,)
        (NNP:[139..146] Somogyi) (NNP:[147..149] AA) (,:[149..150] ,)
        (NNP:[151..158] Bochner) (NNP:[159..160] F) (,:[160..161] ,)
        (NNP:[162..172] Eichelbaum) (NNP:[173..175] M.)))

;section 3 Span:179..268
;Department of Clinical and Experimental Pharmacology, University of Adelaide,
; Australia.
(SEC
  (FRAG (NNP:[179..189] Department) (IN:[190..192] of) (NNP:[193..201] Clinical)
        (CC:[202..205] and) (NNP:[206..218] Experimental)
        (NNP:[219..231] Pharmacology) (,:[231..232] ,)
        (NNP:[233..243] University) (IN:[244..246] of) (NNP:[247..255] Adelaide)
        (,:[255..256] ,) (NNP:[258..267] Australia) (.:[267..268] .)))

;sentence 4 Span:272..409
;1. Codeine O-demethylation to morphine is mediated by cytochrome P450 IID1 
;(rat), or P450 IID6 (man), and exhibits genetic polymorphism.
;[275..282]:substance:"Codeine"
;[302..310]:substance:"morphine"
;[326..346]:cyp450:"cytochrome P450 IID1"
;[326..336]...[358..367]:cyp450:"cytochrome"..."P450 IID6"
(SENT
  (LST (LS:[272..274] 1.))
  (S
    (NP-SBJ-2
      (NP (NN:[275..282] Codeine) (NN:[283..298] O-demethylation))
      (PP (TO:[299..301] to)
        (NP (NN:[302..310] morphine))))
    (VP
      (VP (VBZ:[311..313] is)
        (VP (VBN:[314..322] mediated)
          (NP-2 (-NONE-:[322..322] *))
          (PP (IN:[323..325] by)
            (NP-LGS
              (NP
                
                (NML
                  (NML-1 (NN:[326..336] cytochrome))
                  (NN:[337..341] P450))
                (NN:[342..346] IID1)
                (PRN (-LRB-:[348..349] -LRB-)
                  (NP (NN:[349..352] rat))
                  (-RRB-:[352..353] -RRB-)))
              (,:[353..354] ,) (CC:[355..357] or)
              (NP
                (NML
                  (NML-1 (-NONE-:[357..357] *P*))
                  (NN:[358..362] P450))
                (NN:[363..367] IID6)
                (PRN (-LRB-:[368..369] -LRB-)
                  (NP (NN:[369..372] man))
                  (-RRB-:[372..373] -RRB-)))))))
      (,:[373..374] ,) (CC:[375..378] and)
      (VP (VBZ:[379..387] exhibits)
        (NP (JJ:[388..395] genetic) (NN:[396..408] polymorphism))))
    (.:[408..409] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[272..409]::LST:S:

;sentence 5 Span:410..530
;Thebaine is a  precursor in the formation of endogenous morphine and codeine
;in man, being  O-demethylated to oripavine.
;[410..418]:substance:"Thebaine"
;[425..434]:substance:"precursor"
;[466..474]:substance:"morphine"
;[479..486]:substance:"codeine"
;[520..529]:substance:"oripavine"
(SENT
  (S
    (NP-SBJ (NN:[410..418] Thebaine))
    (VP (VBZ:[419..421] is)
      (NP-PRD
        (NP (DT:[422..423] a) (NN:[425..434] precursor))
        (PP (IN:[435..437] in)
          (NP
            (NP (DT:[438..441] the) (NN:[442..451] formation))
            (PP (IN:[452..454] of)
              (NP
                (NP
                  (ADJP-2 (JJ:[455..465] endogenous))
                  (NN:[466..474] morphine))
                (CC:[475..478] and)
                (NP
                  (ADJP-2 (-NONE-:[478..478] *P*))
                  (NN:[479..486] codeine))))
            (PP (IN:[487..489] in)
              (NP (NN:[490..493] man))))))
      (,:[493..494] ,)
      (S-ADV
        (NP-SBJ-1 (-NONE-:[494..494] *))
        (VP (VBG:[495..500] being)
          (VP (VBN:[502..516] O-demethylated)
            (NP-1 (-NONE-:[516..516] *))
            (PP (TO:[517..519] to)
              (NP (NN:[520..529] oripavine)))))))
    (.:[529..530] .)))

;sentence 6 Span:531..702
;2. The objective of the present study was to  ascertain whether the
;O-demethylation of thebaine to oripavine was mediated by  cytochrome P450
;IID1 in rat liver microsomes.
;[618..626]:substance:"thebaine"
;[630..639]:substance:"oripavine"
;[657..677]:cyp450:"cytochrome P450 IID1"
(SENT
  (LST (LS:[531..533] 2.))
  (S
    (NP-SBJ
      (NP (DT:[534..537] The) (NN:[538..547] objective))
      (PP (IN:[548..550] of)
        (NP (DT:[551..554] the) (JJ:[555..562] present) (NN:[563..568] study))))
    (VP (VBD:[569..572] was)
      (S-NOM-PRP-PRD
        (NP-SBJ (-NONE-:[572..572] *))
        (VP (TO:[573..575] to)
          (VP (VB:[577..586] ascertain)
            (SBAR (IN:[587..594] whether)
              (S
                (NP-SBJ-1
                  (NP (DT:[595..598] the) (NN:[599..614] O-demethylation))
                  (PP (IN:[615..617] of)
                    (NP (NN:[618..626] thebaine)))
                  (PP (TO:[627..629] to)
                    (NP (NN:[630..639] oripavine))))
                (VP (VBD:[640..643] was)
                  (VP (VBN:[644..652] mediated)
                    (NP-1 (-NONE-:[652..652] *))
                    (PP (IN:[653..655] by)
                      (NP-LGS
                        (NML (NN:[657..667] cytochrome) (NN:[668..672] P450))
                        (NN:[673..677] IID1)))
                    (PP-LOC (IN:[678..680] in)
                      (NP (NN:[681..684] rat) (NN:[685..690] liver)
                          (NNS:[691..701] microsomes)))))))))))
    (.:[701..702] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[531..702]::LST:S:

;sentence 7 Span:703..906
;3. Thebaine O-demethylation showed  strain differences in female
;Sprague-Dawley (SD) and female Dark-Agouti (DA)  rats, which serve as a model
;for the human debrisoquine/sparteine metabolism  phenotypes.
;[706..714]:substance:"Thebaine"
;[860..872]:substance:"debrisoquine"
;[873..882]:substance:"sparteine"
(SENT
  (LST (LS:[703..705] 3.))
  (S
    (NP-SBJ (NN:[706..714] Thebaine) (NN:[715..730] O-demethylation))
    (VP (VBD:[731..737] showed)
      (NP (NN:[739..745] strain) (NNS:[746..757] differences))
      (PP-LOC (IN:[758..760] in)
        (NP
          (NP
            (NP (JJ:[761..767] female)
              (NML
                (NML (NNP:[768..775] Sprague) (HYPH:[775..776] -)
                     (NNP:[776..782] Dawley))
                (NML (-LRB-:[783..784] -LRB-) (NNP:[784..786] SD)
                     (-RRB-:[786..787] -RRB-)))
              (NML-2 (-NONE-:[787..787] *P*)))
            (CC:[788..791] and)
            (NP (JJ:[792..798] female)
              (NML
                (NML (NNP:[799..803] Dark) (HYPH:[803..804] -)
                     (NNP:[804..810] Agouti))
                (NML (-LRB-:[811..812] -LRB-) (NNP:[812..814] DA)
                     (-RRB-:[814..815] -RRB-)))
              (NML-2 (NNS:[817..821] rats))))
          (,:[821..822] ,)
          (SBAR
            (WHNP-1 (WDT:[823..828] which))
            (S
              (NP-SBJ-1 (-NONE-:[828..828] *T*))
              (VP (VBP:[829..834] serve)
                (PP-CLR (IN:[835..837] as)
                  (NP
                    (NP (DT:[838..839] a) (NN:[840..845] model))
                    (PP (IN:[846..849] for)
                      (NP (DT:[850..853] the) (JJ:[854..859] human)
                        (NML (NN:[860..872] debrisoquine) (SYM:[872..873] /)
                             (NN:[873..882] sparteine))
                        (NN:[883..893] metabolism) (NNS:[895..905] phenotypes)))))))))))
    (.:[905..906] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[703..906]::LST:S:

;sentence 8 Span:907..1075
;4. The total intrinsic clearance of thebaine to oripavine was high  (19.7
;ml/h per mg protein) in SD rats, indicating that oripavine is a major 
;metabolite of thebaine.
;[943..951]:substance:"thebaine"
;[955..964]:substance:"oripavine"
;[976..980]:quantitative-value:"19.7"
;[981..1000]:quantitative-units:"ml/h per mg protein"
;[1030..1039]:substance:"oripavine"
;[1052..1062]:substance:"metabolite"
;[1066..1074]:substance:"thebaine"
(SENT
  (LST (LS:[907..909] 4.))
  (S
    (NP-SBJ
      (NP (DT:[910..913] The) (JJ:[914..919] total) (JJ:[920..929] intrinsic)
          (NN:[930..939] clearance))
      (PP (IN:[940..942] of)
        (NP (NN:[943..951] thebaine)))
      (PP (TO:[952..954] to)
        (NP (NN:[955..964] oripavine))))
    (VP (VBD:[965..968] was)
      (ADJP-PRD (JJ:[969..973] high)
        (PRN (-LRB-:[975..976] -LRB-)
          (NP
            (NP (CD:[976..980] 19.7) (NN:[981..983] ml))
            (PP (SYM:[983..984] /)
              (NP (NN:[984..985] h)))
            (PP (IN:[986..989] per)
              (NP (NN:[990..992] mg) (NN:[993..1000] protein))))
          (-RRB-:[1000..1001] -RRB-)))
      (PP-LOC (IN:[1002..1004] in)
        (NP (NNP:[1005..1007] SD) (NNS:[1008..1012] rats)))
      (,:[1012..1013] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1013..1013] *))
        (VP (VBG:[1014..1024] indicating)
          (SBAR (IN:[1025..1029] that)
            (S
              (NP-SBJ (NN:[1030..1039] oripavine))
              (VP (VBZ:[1040..1042] is)
                (NP-PRD
                  (NP (DT:[1043..1044] a) (JJ:[1045..1050] major)
                      (NN:[1052..1062] metabolite))
                  (PP (IN:[1063..1065] of)
                    (NP (NN:[1066..1074] thebaine))))))))))
    (.:[1074..1075] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[907..1075]::LST:S:

;sentence 9 Span:1076..1162
;A 3-fold lower intrinsic clearance was observed in DA  rats (6.7 ml/h per mg
;protein).
;[1078..1084]:quantitative-value:"3-fold"
;[1137..1140]:quantitative-value:"6.7"
;[1141..1160]:quantitative-units:"ml/h per mg protein"
(SENT
  (S
    (NP-SBJ-1 (DT:[1076..1077] A)
      (ADJP
        (QP (CD:[1078..1079] 3) (HYPH:[1079..1080] -) (RB:[1080..1084] fold))
        (JJR:[1085..1090] lower))
      (JJ:[1091..1100] intrinsic) (NN:[1101..1110] clearance))
    (VP (VBD:[1111..1114] was)
      (VP (VBN:[1115..1123] observed)
        (NP-1 (-NONE-:[1123..1123] *))
        (PP-LOC (IN:[1124..1126] in)
          (NP (NNP:[1127..1129] DA) (NNS:[1131..1135] rats)))
        (PRN (-LRB-:[1136..1137] -LRB-)
          (NP
            (NP (token:[1137..1140] 6.7) (NN:[1141..1143] ml))
            (PP (SYM:[1143..1144] /)
              (NP (NN:[1144..1145] h)))
            (PP (IN:[1146..1149] per)
              (NP (NN:[1150..1152] mg) (NN:[1153..1160] protein))))
          (-RRB-:[1160..1161] -RRB-))))
    (.:[1161..1162] .)))

;sentence 10 Span:1163..1362
;5. Thebaine O-demethylation was inhibited by  quinine and known substrates of
;cytochrome P450 IID1/P450 IID6, supporting the  major involvement of
;cytochrome P450 IID1 in oripavine formation in rats.
;[1166..1174]:substance:"Thebaine"
;[1209..1216]:substance:"quinine"
;[1227..1237]:substance:"substrates"
;[1241..1261]:cyp450:"cytochrome P450 IID1"
;[1241..1251]...[1262..1271]:cyp450:"cytochrome"..."P450 IID6"
;[1310..1330]:cyp450:"cytochrome P450 IID1"
;[1334..1343]:substance:"oripavine"
(SENT
  (LST (LS:[1163..1165] 5.))
  (S
    (NP-SBJ-1 (NN:[1166..1174] Thebaine) (NN:[1175..1190] O-demethylation))
    (VP (VBD:[1191..1194] was)
      (VP (VBN:[1195..1204] inhibited)
        (NP-1 (-NONE-:[1204..1204] *))
        (PP (IN:[1205..1207] by)
          (NP-LGS
            (NP (NN:[1209..1216] quinine))
            (CC:[1217..1220] and)
            (NP
              (NP (VBN:[1221..1226] known) (NNS:[1227..1237] substrates))
              (PP (IN:[1238..1240] of)
                (NP
                  (NP
                    (NML
                      (NML-2 (NN:[1241..1251] cytochrome))
                      (NN:[1252..1256] P450))
                    (NN:[1257..1261] IID1))
                  (SYM:[1261..1262] /)
                  (NP
                    (NML
                      (NML-2 (-NONE-:[1262..1262] *P*))
                      (NN:[1262..1266] P450))
                    (NN:[1267..1271] IID6)))))))
        (,:[1271..1272] ,)
        (S-ADV
          (NP-SBJ (-NONE-:[1272..1272] *))
          (VP (VBG:[1273..1283] supporting)
            (NP
              (NP (DT:[1284..1287] the) (JJ:[1289..1294] major)
                  (NN:[1295..1306] involvement))
              (PP (IN:[1307..1309] of)
                (NP (NN:[1310..1320] cytochrome) (NN:[1321..1325] P450)
                    (NN:[1326..1330] IID1)))
              (PP (IN:[1331..1333] in)
                (NP
                  (NP (NN:[1334..1343] oripavine) (NN:[1344..1353] formation))
                  (PP-LOC (IN:[1354..1356] in)
                    (NP (NNS:[1357..1361] rats))))))))))
    (.:[1361..1362] .)))
;ERROR_Sentence has multiple Children (Sentence Error)[1163..1362]::LST:S:

;section 11 Span:1366..1409
;PMID: 1763524 [PubMed - indexed for MEDLINE
(SEC
  (FRAG (NNP:[1366..1370] PMID) (::[1370..1371] :) (CD:[1372..1379] 1763524)
        (-LRB-:[1380..1381] -LSB-) (NNP:[1381..1387] PubMed) (::[1388..1389] -)
        (VBN:[1390..1397] indexed) (IN:[1398..1401] for)
        (NNP:[1402..1409] MEDLINE)))
;ERROR_Orphan Text from EOF Tree File[1409..EOF] ]

(ORPH -RSB-)
